2019-nCoV
Showing 26 - 50 of 2,686
Development ofSimple, Fast and Portable Recombinase Aided
Unknown status
- New Coronavirus
- Recombinase aided amplification (RAA) assay
-
Beijing, Beijing, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital
Apr 9, 2020
COVID-19 Complicated With Refractory Intestinal Infections Trial in Nanjing (washed microbiota transplantation, )
Withdrawn
- COVID-19 Complicated With Refractory Intestinal Infections
- washed microbiota transplantation
- placebo
-
Nanjing, Jiangsu, ChinaMedical Center for Digestive Diseases, The Second Affiliated Hos
Mar 13, 2020
COVID-19, Corona Virus Infection, SARS-CoV-2 Trial in Portland (Hydroxychloroquine, Vitamin C)
Suspended
- COVID-19
- +4 more
- Hydroxychloroquine
- Vitamin C
-
Portland, OregonPortland Providence Medical Center
Sep 14, 2020
2019 Novel Coronavirus Infection Trial in Shiyan (recombinant human interferon Alpha-1b, thymosin alpha 1)
Unknown status
- 2019 Novel Coronavirus Infection
- recombinant human interferon Alpha-1b
- thymosin alpha 1
-
Shiyan, Hubei, ChinaTaihe Hospital
Mar 30, 2020
Effects of 2019-novel Coronavirus
Unknown status
- Pneumonia Caused by Human Coronavirus
-
Fuzhou, Fujian, ChinaFujian Provincial Hospital
Feb 29, 2020
2019-nCoV Outbreak and Cardiovascular Diseases
Unknown status
- Cardiovascular Death; Major Adverse Cardiovascular Events
-
Binzhou, Shandong, China
- +11 more
Feb 3, 2020
Novel Coronavirus Pneumonia Trial in Xinxiang (NK Cells)
Recruiting
- Novel Coronavirus Pneumonia
- NK Cells
-
Xinxiang, Henan, ChinaThe First Affiliated Hospital of Xinxiang Medical University
Aug 31, 2022
SARS (Severe Acute Respiratory Syndrome), Coronavirus Trial in Sweden, United States (Nitric Oxide Gas)
Completed
- SARS (Severe Acute Respiratory Syndrome)
- Coronavirus
- Nitric Oxide Gas
-
Birmingham, Alabama
- +4 more
Jun 20, 2022
Novel Coronavirus Infection Trial in Hong Kong (Lopinavir/ritonavir, Ribavirin, Interferon Beta-1B)
Completed
- Novel Coronavirus Infection
- Lopinavir/ritonavir
- +2 more
-
Hong Kong, Hong KongUniversity of Hong Kong, Queen Mary Hospital
Apr 13, 2020
COVID19 Trial in Boston (Nitric Oxide Gas, Inhaled Supplemental Oxygen)
Terminated
- COVID19
- Nitric Oxide Gas
- Inhaled Supplemental Oxygen
-
Boston, MassachusettsMassachusetts General Hospital
Dec 15, 2021
Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)
Completed
- Healthy Adult Volunteers
- ChAdOx1-nCov-19 (Astra-Zeneca)
- SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
-
Taipei City, X, TaiwanNational Taiwan University Hospital
Oct 16, 2022
COVID-19 Trial in France (hospitalized children with Covid19)
Recruiting
- COVID-19
- hospitalized children with Covid19
-
Saint Denis, La Réunion, France
- +75 more
Nov 21, 2022
Acute Abdomen (Non-surgical and Surgical Causes) in COVID-19
Completed
- Acute Abdomen
- medical ,oncological and surgical treatment of cases of acute abdomen
-
Zagazig, Sharkia, EgyptTamer Alnaimy
Sep 5, 2022
Adenovirus Type-5 Vectored COVID-19 Vaccine Trial in Wuhan (Adenovirus Type-5 Vectored COVID-19 Vaccine)
Completed
- Adenovirus Type-5 Vectored COVID-19 Vaccine
- Adenovirus Type-5 Vectored COVID-19 Vaccine
-
Wuhan, Hubei, ChinaA rehabilitation centre in Wuhan
Mar 28, 2022
COVID-19 Breakthrough Infection in Fully Vaccinated People and
Enrolling by invitation
- COVID-19 Pneumonia
- COVID-19
- Pfizer COVID-19 mRNA vaccine
- Moderna COVID-19 mRNA vaccine
-
Dallas, TexasMethodist Dallas Medical Center
May 24, 2022
SARS-CoV-2 Trial (SARS-CoV-2 mRNA Vaccine, Bivalent Low dose, SARS-CoV-2 mRNA Vaccine, Bivalent High dose, Placebo)
Recruiting
- SARS-CoV-2
- SARS-CoV-2 mRNA Vaccine, Bivalent Low dose
- +2 more
-
Bengbu, Anhui, ChinaFirst Affiliated Hospital Bengbu Medical College
Jan 3, 2023
SARS-CoV-2 Trial (SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose
- +2 more
- (no location specified)
Dec 1, 2022
SARS-CoV-2, Covid19 Trial in Brussels (Serological testing)
Recruiting
- SARS-CoV-2
- Covid19
- Serological testing
-
Brussels, BelgiumUZ Brussel
May 17, 2022
Xerostomia, COVID-19, Long COVID Trial in Sao Paulo (Institutional standard treatment for xerostomia and Long Covid,
Recruiting
- Xerostomia
- +3 more
- Institutional standard treatment for xerostomia and Long Covid
- +2 more
-
Sao Paulo, BrazilUniversidade Nove de Julho / Post-Graduate program Biophotonics
Mar 7, 2023
COVID-19 Trial in Entebbe (LNP-nCOV saRNA-02 Vaccine)
Recruiting
- COVID-19
- LNP-nCOV saRNA-02 Vaccine
-
Entebbe, UgandaMRC/UVRI & LSHTM Uganda Research Unit
Apr 14, 2022
COVID-19 Trial in Wuhan (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector))
Completed
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
-
Wuhan, Hubei, ChinaHubei Provincial Center for Disease Control and Prevention
Aug 2, 2021
SARS-CoV-2 RBD Antibody in My Duc Hospital Healthcare Workers
Completed
- Covid19
- Vaccine Reaction
- SARS-CoV-2 IgG II Quant
-
Ho Chi Minh City, Tan Binh, VietnamHOPE Research Center, My Duc Hospital
Aug 20, 2022
Covid19 Trial in France (Performance of the test antigenic and test RT-PCR)
Completed
- Covid19
- Performance of the test antigenic and test RT-PCR
-
Créteil, France
- +3 more
Dec 1, 2020
Corona Virus Infection, Pregnancy Related Trial in Falls Church (COVID-19 positive via testing)
Completed
- Corona Virus Infection
- Pregnancy Related
- COVID-19 positive via testing
-
Falls Church, VirginiaINOVA Health System
Apr 5, 2022